Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 1
2013 4
2014 3
2015 3
2016 3
2017 1
2018 1
2019 2
2020 1
2021 1
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-1α.
Rider P, Carmi Y, Voronov E, Apte RN. Rider P, et al. Semin Immunol. 2013 Dec 15;25(6):430-8. doi: 10.1016/j.smim.2013.10.005. Epub 2013 Nov 1. Semin Immunol. 2013. PMID: 24183701 Review.
Alarmins: Feel the Stress.
Rider P, Voronov E, Dinarello CA, Apte RN, Cohen I. Rider P, et al. J Immunol. 2017 Feb 15;198(4):1395-1402. doi: 10.4049/jimmunol.1601342. J Immunol. 2017. PMID: 28167650 Review.
T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors.
Rasoulouniriana D, Santana-Magal N, Gutwillig A, Farhat-Younis L, Tal L, Amar S, Milyavsky M, Muddineni SSNA, Solomon N, Shpilt H, Dotan S, Pilpel N, Waskow C, Feinmesser M, Rider P, Carmi Y. Rasoulouniriana D, et al. Among authors: rider p. Cancer Immunol Res. 2023 Jun 2;11(6):792-809. doi: 10.1158/2326-6066.CIR-22-0423. Cancer Immunol Res. 2023. PMID: 37070661 Free PMC article.
A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity.
Rasoulouniriana D, Santana-Magal N, Gutwillig A, Farhat-Younis L, Wine Y, Saperia C, Tal L, Gutman H, Tsivian A, Brenner R, Bandora EA, Reticker-Flynn NE, Rider P, Carmi Y. Rasoulouniriana D, et al. Among authors: rider p. J Clin Invest. 2019 Oct 1;129(10):4151-4164. doi: 10.1172/JCI127590. J Clin Invest. 2019. PMID: 31449054 Free PMC article.
Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy.
Santana-Magal N, Farhat-Younis L, Gutwillig A, Gleiberman A, Rasoulouniriana D, Tal L, Netanely D, Shamir R, Blau R, Feinmesser M, Zlotnik O, Gutman H, Linde IL, Reticker-Flynn NE, Rider P, Carmi Y. Santana-Magal N, et al. Among authors: rider p. Cancer Res. 2020 May 15;80(10):1942-1956. doi: 10.1158/0008-5472.CAN-19-2944. Epub 2020 Mar 3. Cancer Res. 2020. PMID: 32127354
Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy.
Gutwillig A, Santana-Magal N, Farhat-Younis L, Rasoulouniriana D, Madi A, Luxenburg C, Cohen J, Padmanabhan K, Shomron N, Shapira G, Gleiberman A, Parikh R, Levy C, Feinmesser M, Hershkovitz D, Zemser-Werner V, Zlotnik O, Kroon S, Hardt WD, Debets R, Reticker-Flynn NE, Rider P, Carmi Y. Gutwillig A, et al. Among authors: rider p. Elife. 2022 Sep 20;11:e80315. doi: 10.7554/eLife.80315. Elife. 2022. PMID: 36124553 Free PMC article.
26 results